Patents by Inventor Theresa A. Lansdell

Theresa A. Lansdell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE ENHANCEMENT OF 20S PROTEASOME ACTIVITY TARGETS INTRINSICALLY DISORDERED PROTEINS
    Publication number: 20230002335
    Abstract: The disclosure is directed to compounds of the formula (I) and (II) and uses of such compounds to treat, among other conditions, neurodegenerative diseases and cancers.
    Type: Application
    Filed: February 14, 2022
    Publication date: January 5, 2023
    Inventors: Jetze J. Tepe, Theresa A. Lansdell, Evert Njomen, Corey Lee Jones
  • Substituted phenothiazines as proteasome activators
    Patent number: 11358942
    Abstract: The disclosure is directed to compounds of the formula (I): and uses of such compounds to treat neurodegenerative diseases and cancers.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: June 14, 2022
    Assignee: Board of Trustees of Michigan State University
    Inventors: Jetze J. Tepe, Theresa A. Lansdell, Evert Njomen, Corey Lee Jones
  • QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF
    Publication number: 20220048861
    Abstract: Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.
    Type: Application
    Filed: February 4, 2021
    Publication date: February 17, 2022
    Inventors: Aaron Odom, Jetze J. Tepe, Theresa A. Lansdell
  • QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF
    Publication number: 20200347019
    Abstract: Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.
    Type: Application
    Filed: July 20, 2020
    Publication date: November 5, 2020
    Inventors: Aaron Odom, Jetze J. Tepe, Theresa A. Lansdell
  • Quinoline-based proteasome inhibitors and uses thereof
    Patent number: 10752590
    Abstract: Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: August 25, 2020
    Assignee: Board of Trustees of Michigan State University
    Inventors: Aaron Odom, Jetze J. Tepe, Theresa A. Lansdell
  • QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF
    Publication number: 20180282280
    Abstract: Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.
    Type: Application
    Filed: March 29, 2018
    Publication date: October 4, 2018
    Inventors: Aaron Odom, Jetze J. Tepe, Theresa A. Lansdell